Uncovering Parkinson’s Biomarkers Through Red Blood Cell Proteins

Mapping the Red Blood Cell Proteome to Identify Parkinson's Disease Biomarkers Uncovering Parkinson’s Biomarkers Through Red Blood Cell Proteins This webinar will present recent advances in deep proteomic profiling of human red blood cells for the discovery of biomarkers associated with Parkinson’s disease. Leveraging state-of-the-art Bruker mass spectrometry platforms, we have identified protein signatures that may enable earlier detection and improved monitoring of disease progression. Attendees will gain insight into sample preparation strategies, data acquisition using DIA and TIMS-TOF technology, and bioinformatics workflows for biomarker validation. Red blood cells (RBCs) offer a unique and minimally invasive window into neurodegeneration, yet their potential as a source of Parkinson’s disease biomarkers is only beginning to be explored. This webinar will showcase state-of-the-art mass spectrometry (MS) platforms that are able to identify protein signatures linked to earlier detection and improved disease monitoring. Our expert speaker will share new findings from RBC proteomics research, offering attendees a look at how this exciting area of proteomics and high-resolution MS may advance our understanding and clinical management of Parkinson’s disease.